| Date | Investigators | Affiliation | Project Title |
Nov 2009 Due December 2011
Full Application
|
Paul James, Gillian Mitchell, Alison Trainer, Judy Kirk, John Hopper; Melissa Southey, Stephen Fox, Ian Campbell
|
Peter MacCallum Cancer Centre, University of Melbourne, Westmead Hopital Sydney
|
Focus on pancreatic cancer
|
February 2010, due December 2011
Pilot application
|
Ashok Venkitaraman et al
|
Hutchison/MRC Research Centre, University of Cambridge, UK
|
Germline BRCA2 mutation carriers are at an increased risk of pancreatic ductal adenocarninoma.
|
April 2011, due December 2011
Full Application
|
Sunil Lakhani, Ernst Wolvetang, Chanel Smart, Jodi Saunus
|
University of Queensland Centre for Clinical Research (UQCCR)
|
Applying inducible pluripotent stem (iPS) cell technology to study mammary differentiation and breast cancer susceptibility.
|
JUne 2011, due December 2011
Full application
|
Chris Haiman, Tom Mack, John Hopper, Melissa Southey, Graham Giles
|
USC Keck School of Medicine, in Los Angeles, The University of Melbourne, The Cancer Council of Victoria, The Peter MacCallum Cancer Centre
|
A GWAS study involving women in kConFab who are known non-carriers of BRCA1 and BRCA2 mutations and are at the highest level of “polygenic” risk.
|
27th July 2011
Full Project
|
Simon Gayther
|
University of Southern California, USA
|
Linking risk associated SNPs for ovarian cancer to target genes in susceptibility regions
|
September 2011
Full Application
|
David Bowtell and the AOCS team
|
Peter MacCallum Cancer Centre
|
The role of CCNE1 amplification in breast cancer
|
November 2011, due May 2012
Full application
|
Andrea Bild
|
Department of Pharmacology and Toxicology, Utah University, Salt Lake City, USA
|
Do deregulated gene and protein expression levels predict breast cancer risk and reveal novel signaling pathways involved in familial breast cancer?
|
November 2011, due May 2012
Full Project
|
John Heath & John Hopper
|
The Children's Hospiotal and The University of Melbourne, Melbourne
|
Childhood cancer in families with BRCA1 or BRCA2 mutations ascertained via a high-risk breast cancer database.
|
December 2011
Full Project
|
John Hopper, Mary Beth Terry et al.
|
The University fo Melbourne
|
Expression of Interest: Genes, environment and breast cancer risk: the 15 year follow-up of the ProF-SC.
|
Jnauary 2012, full application due June 2012
Full Project
|
Goli Samimi
|
Cancer Research Program, Garvan Institute of Medical Research, NSW
|
Development of a Blood-Based DNA Methylation Assay for Screening of High Grade Serous Ovarian Cancer in High Risk Women
|
January 2012 application due June 2012
Full Project
|
Gail Risbridger, Patrick Humbert, Gillian Mitchell and Scott Williams.
|
Monash Medical Centre, Peter MacCallum Cancer Centre, Melbourne.
|
The Cancer of Prostate Translational Research In Victoria (CAPTIV) Collaboration.
|
January 2012, application due June 2012
Full application
|
Anthony Swerdlow
|
Institute of Cancer Research, UK
|
Collaborative international Genome-wide Association Study (GWAS) of genetic susceptibility to breast cancer in men
|
A pilot or full application must be made within 6 months of submitting the letter
of intent. If more than six months has elapsed, a new letter of intent must be submitted
prior to the full application.